Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Eduardo Sprinz"'
Autor:
Wonyeong Jung, Dansu Yuan, Benjamin Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Igor Smolenov, Galit Alter, Ryan P. McNamara, Sue Ann Costa Clemens
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-10 (2024)
Abstract With the continued emergence of variants of concern, the global threat of COVID-19 persists, particularly in low- and middle-income countries with limited vaccine access. Protein-based vaccines, such as SCB-2019, can be produced on a large s
Externí odkaz:
https://doaj.org/article/718ae9b1dfb44fbcb54c0861cbdcc9e0
Autor:
Judith A. Aberg, Bronagh Shepherd, Marcia Wang, Jose V. Madruga, Fernando Mendo Urbina, Christine Katlama, Shannon Schrader, Joseph J. Eron, Princy N. Kumar, Eduardo Sprinz, Margaret Gartland, Shiven Chabria, Andrew Clark, Amy Pierce, Max Lataillade, Allan R. Tenorio
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 9, Pp 2321-2335 (2023)
Abstract Introduction Efficacy and safety of the attachment inhibitor fostemsavir + optimized background therapy (OBT) were evaluated through 48 and 96 weeks in the phase 3 BRIGHTE trial in heavily treatment-experienced (HTE) adults failing their cur
Externí odkaz:
https://doaj.org/article/8218d8a5b6c34c1bb1da2843ae2d87e4
Autor:
Fernando Carvalho Neuenschwander, Ofra Barnett-Griness, Stefania Piconi, Yasmin Maor, Eduardo Sprinz, Nimer Assy, Oleg Khmelnitskiy, Nikita V. Lomakin, Boris Mikhailovich Goloshchekin, Ewelina Nahorecka, Adilson Joaquim Westheimer Calvacante, Anastasia Ivanova, Sergey Vladimirovich Zhuravel, Galina Yurevna Trufanova, Stefano Bonora, Amer Saffoury, Ami Mayo, Yury G. Shvarts, Giuliano Rizzardini, Rogerio Sobroza de Mello, Janaina Pilau, Alexey Klinov, Benjamin Valente-Acosta, Oleg Olegovich Burlaka, Natalia Bakhtina, Maskit Bar-Meir, Ivan Nikolaevich Shishimorov, Jose Oñate-Gutierrez, Cristian Iván García Rincón, Tatiana Ivanovna Martynenko, Ludhmila Abrahão Hajjar, Ana Carolina Nazare de Mendonca Procopio, Krzysztof Simon, Walter Gabriel Chaves Santiago, Adam Fronczak, Conrado Roberto Hoffmann Filho, Osama Hussein, Vladimir Aleksandrovich Martynov, Guido Chichino, Piotr Blewaska, Jacek Wroblewski, Sergio Saul Irizar Santana, Andres Felipe Ocampo Agudelo, Adam Barczyk, Rachael lask Gerlach, Eppie Campbell, Aida Bibliowicz, Reza Fathi, Patricia Anderson, Gilead Raday, Michal Klein, Clara Fehrmann, Gina Eagle, Vered Katz Ben-Yair, Mark L. Levitt
Publikováno v:
Microorganisms, Vol 12, Iss 9, p 1767 (2024)
Once a patient has been diagnosed with severe COVID-19 pneumonia, treatment options have limited effectiveness. Opaganib is an oral treatment under investigation being evaluated for treatment of hospitalized patients with severe COVID-19 pneumonia. A
Externí odkaz:
https://doaj.org/article/4abee192ba974c30b03ccb75515ad1f3
Autor:
Carlos Brites, Marcus Lacerda, Eduardo Sprinz, Monica Bay, Gustavo Pinto, Pollyanna Azevedo, Estela Luz, Liliane Lins-Kusterer, Eduardo M. Netto
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundCurrently, integrase inhibitors (INIs)-based ART regimens are the preferred initial therapy for AIDS patients. There is scarce information on the use of dolutegravir (DTG) among late-presenter people living with HIV (PLHIV).ObjectivesTo com
Externí odkaz:
https://doaj.org/article/45982b7e9171492da864fc0d14e04429
Autor:
Alessandro C Pasqualotto, Flavio Queiroz-Telles, Alberto Chebabo, Terezinha M J S Leitao, Diego R Falci, Melissa O Xavier, Monica B Bay, Eduardo Sprinz, Daiane Dalla Lana, Adriana P Vincentini, Lisandra Serra Damasceno, Alexandre V Schwarzbold, Paulo Abrão Ferreira, Cassia Miranda Godoy, Jose Ernesto Vidal, Rossana Basso, Candida Driemeyer, Valerio R Aquino, Cecilia B Severo, Marcelo Simão Ferreira, Claudilson Bastos, Filipe Prohaska, Marineide Melo, Francelise Bridi Cavassin, Marcus Lacerda, Renata Soares, Rosely Zancope-Oliveira, Marcus Teixeira, Freddy Perez, Diego H Caceres, Juan Luis Rodriguez-Tudela, Tom Chiller, Arnaldo L Colombo
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 1, p e0010960 (2023)
Externí odkaz:
https://doaj.org/article/2a6fea4bcc3c43bd826c22a070aa9748
Autor:
Sue Ann Costa Clemens, Pedro M. Folegatti, Katherine R. W. Emary, Lily Yin Weckx, Jeremy Ratcliff, Sagida Bibi, Ana Verena De Almeida Mendes, Eveline Pipolo Milan, Ana Pittella, Alexandre V. Schwarzbold, Eduardo Sprinz, Parvinder K. Aley, David Bonsall, Christophe Fraser, Michelle Fuskova, Sarah C. Gilbert, Daniel Jenkin, Sarah Kelly, Simon Kerridge, Teresa Lambe, Natalie G. Marchevsky, Yama F. Mujadidi, Emma Plested, Maheshi N. Ramasamy, Peter Simmonds, Tanya Golubchik, Merryn Voysey, Andrew J. Pollard, the AMPHEUS Project, Oxford COVID Vaccine Trial Team
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Emerging variants of SARS-CoV-2 raise concerns about vaccine efficiency. Here, the authors present a post-hoc analysis for the ChAdOx1 nCoV-19 (AZD1222) vaccine trial in Brazil and provide efficacy against symptomatic COVID-19 caused by the Zeta (P.2
Externí odkaz:
https://doaj.org/article/2174b542d59f4531bfbfd908fa719572
Autor:
Marina Ferri-Pezzini, Hugo Cheinquer, Alexandre de Araujo, Carlos T. Schmidt-Cerski, Eduardo Sprinz, Fernando Herz-Wolff, Julia Poeta
Publikováno v:
Annals of Hepatology, Vol 24, Iss , Pp 100368- (2021)
Introduction: Chronic liver disease is an important cause of morbidity and mortality among people living with human immunodeficiency virus (HIV) and is frequently related to non-alcoholic fatty liver disease (NAFLD). Objective: The objective is to es
Externí odkaz:
https://doaj.org/article/35ecde1f7b7b43f79e5cf292c9a66852
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/c2f64e6559384ef395050a323eafc0c6
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 24, Iss 5, Pp 455-457 (2020)
COVID-19 pandemic has been a problem worldwide. It is important to identify people at risk of progressing to severe complications and to investigate if some existing antivirals could have any action against SARS-CoV-2. In this context, HIV-infected i
Externí odkaz:
https://doaj.org/article/3b7e0b12723e49d19a41370008145408
Autor:
Marineide Gonçalves de Melo, Eduardo Sprinz, Pamina M. Gorbach, Breno Santos, Tauí de Melo Rocha, Mariana Simon, Marcelo Almeida, Rita Lira, Maria Cristina Chaves, Tara Kerin, Ivana Varella, Karin Nielsen-Saines
Publikováno v:
International Journal of Infectious Diseases, Vol 87, Iss , Pp 128-134 (2019)
Objectives: HIV-1 heterosexual transmission among individuals on antiretroviral treatment (ART) with undetectable viremia is extremely rare. The aim of this study was to evaluate the risk of sexual HIV-1 transmission and other sexually transmitted in
Externí odkaz:
https://doaj.org/article/62cd694c69f647de8f0ca39e3cba0f5f